NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/04/2022
Back to search
Official data from USPTO
ADAPTIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADAPTIVE
ST13
US500000087878532Class
42, 44
Filing
87878532
Registration
6866517
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
10/04/2022
Trademark type
Word
Nice classes
42, 44
Filing date
04/16/2018
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
10/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/08/2009
First use in commerce
09/08/2009
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
CHADAB, SETH
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. C. (pessoa física)
Representatives
Hoang-chi Truong Patent Law Works LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expressioncancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapyoncologyhematologyauto-immune disordersinfectious diseases; medical and scientific research in the field of immunotherapy
Class 44
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals determine a patient's clinical diagnosisthe effectiveness of patient treatmentsto revise future treatments accordingly
Publications
History of USPTO decisions and trademark events.
52 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/30/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/29/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/05/2022
EX1G
SOU EXTENSION 1 GRANTED
08/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/01/2022
EXT1
SOU EXTENSION 1 FILED
07/15/2022
IUAF
USE AMENDMENT FILED
07/15/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/15/2022
EISU
TEAS STATEMENT OF USE RECEIVED
07/15/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/18/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
12/07/2021
OP.D
OPPOSITION DISMISSED NO. 999999
12/07/2021
TTBN
CASE ASSIGNED TO TTAB
12/10/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/10/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/18/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/08/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
07/07/2020
OP.T
OPPOSITION TERMINATED NO. 999999
07/07/2020
OP.D
OPPOSITION DISMISSED NO. 999999
07/07/2020
PCDE
PETITION TO DIRECTOR DENIED
09/27/2019
APET
ASSIGNED TO PETITION STAFF
08/19/2019
APET
ASSIGNED TO PETITION STAFF
06/20/2019
APET
ASSIGNED TO PETITION STAFF
05/24/2019
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
04/17/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/16/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
11/19/2018
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
11/19/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
ALIE
ASSIGNED TO LIE
10/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/08/2018
GNRT
NON-FINAL ACTION E-MAILED
08/08/2018
CNRT
NON-FINAL ACTION WRITTEN
08/08/2018
DOCK
ASSIGNED TO EXAMINER
08/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/24/2018
NWAP
NEW APPLICATION ENTERED
04/19/2018
Continuous trademark protection
Get notified about every new filing that threatens ADAPTIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.